Menaquinone-4 (MK-4) and menaquinone-7 (MK-7), the bioactive forms of vitamin K2, have been shown to modulate insulin signaling, suppress hepatic lipogenesis, and reduce inflammation, thereby contributing to improved lipid profiles and reduced hepatic steatosis [14,15,16]. This evidence concerns the gene INS and fatty liver disease.